Emanuelsson H, Hjalmarson A, Holmberg S, Waagstein F
J Cardiovasc Pharmacol. 1986 May-Jun;8(3):500-6. doi: 10.1097/00005344-198605000-00010.
We determined hemodynamics and myocardial lactate extraction in 11 patients with severe coronary disease after 0.010 (D1), 0.015 (D2), and 0.025 nmol/min (D3) of the arteriolar dilator felodipine during pacing-induced angina pectoris. Plasma concentrations of felodipine after the 3 doses were 12 (5), 25 (6) and 43 (8) nmol/ L, respectively. At corresponding pacing rates, mean blood pressure fell from 126 (24) to 90 (15) mm Hg at D3 (p less than 0.01) and pulmonary capillary wedge pressure was reduced from 14 (10) to 9 (8) mm Hg (p less than 0.05). Cardiac output increased at all three doses (p less than 0.01). The reduction of systemic vascular resistance at D3 was 49% (p less than 0.01) and of coronary vascular resistance 35% (p less than 0.05). At D1, there was no change in lactate extraction, while 8/10 lactate producers improved at D2 and D3. ST depression was diminished at all three doses (p less than 0.05) at the control pacing rate. During maximal pacing rate at D3, the myocardial oxygen consumption was 14% above control level (N.S.). Thus, felodipine was beneficial in most patients at higher dosage. Ventricular unloading and improved coronary perfusion might explain some of these positive effects.
我们测定了11例严重冠心病患者在起搏诱发心绞痛期间,给予小动脉扩张剂非洛地平0.010(D1)、0.015(D2)和0.025 nmol/min(D3)后的血流动力学和心肌乳酸摄取情况。3次给药后非洛地平的血浆浓度分别为12(5)、25(6)和43(8)nmol/L。在相应的起搏频率下,D3时平均血压从126(24)mmHg降至90(15)mmHg(p<0.01),肺毛细血管楔压从14(10)mmHg降至9(8)mmHg(p<0.05)。所有3个剂量下的心输出量均增加(p<0.01)。D3时全身血管阻力降低49%(p<0.01),冠状动脉血管阻力降低35%(p<0.05)。在D1时,乳酸摄取无变化,而在D2和D3时,10名乳酸产生者中有8名情况改善。在对照起搏频率下,所有3个剂量时ST段压低均减轻(p<0.05)。在D3的最大起搏频率时,心肌氧耗比对照水平高14%(无统计学意义)。因此,非洛地平在较高剂量时对大多数患者有益。心室负荷减轻和冠状动脉灌注改善可能解释了其中一些积极作用。